Ваш язык русский?
Zydus Heptiza: cure for hepatitis C
Zydus is a fully integrated, global healthcare provider, with strengths all along the pharmaceutical value chain. With a core competence in the field of healthcare, Zydus provides total healthcare solutions ranging from formulations, active pharmaceutical ingredients and animal healthcare products to wellness products.
Our mission is to create a healthy society
For 65 years of existence, the company has moved from a small producer to a global holding with more than 13,000 employees and an annual turnover of $ 7.5 billion. Holding is the second largest in India and one of the top 100 largest manufacturers of medical products.
In 2012, there was a breakthrough in the treatment of hepatitis C: new antiviral drugs of direct action were developed. They show high efficiency, almost no side effects and are easily tolerated. Zydus Heptiza is licensed under the license of Gilead Sciences Inc. and produces in India the drugs SoviHep (Sofosbuvir), Dacihep (Daclatasvir), LediHep (Ledipasvir) and Sovihep V (Sofosbuvir + Velpatasvir). This assortment covers the entire range of prescribed hepatitis C treatment regimens.
Good health, happiness, joy, growth, togetherness, discovery, learning, exploration, evolution, transformation, aspirations, are all intrinsically linked with life. Zydus Heptiza is dedicated to all these dimensions.
Through these initiatives, Zydus Heptiza reaches out to the community that it forms a part of, finding new expressions for its mission to create healthier communities globally. Zydus Heptiza has forged meaningful partnerships with its key stakeholders both internal and external, partners in progress and the community at large. Ethical practices, accountability, robust governance and sustainable initiatives are at the very core of the group’s business strategy, planning and operations which helps minimise risks and leverage opportunities to create value. The group’s philosophy for community engagement is based on the principle of volunteerism and is an intensive, comprehensive and sustainable programme.
1). Our Company was awarded the Overall India Pharma Excellence Award and the India Pharma Innovation of the Year Award from the Department of Pharmaceuticals, Government of India.
2). Recently, the Zydus group bagged the India Pharma Overall Excellence Award and India Pharma Innovation of the Year Award from the Govt. of India.
3). The group also won the CII Industrial Innnovation Grand Jury Award of being the Most Innovative Company of the Year and declared the most Innovative Pharmaceutical Company by Thomsun Reuters.